Progesterone receptor action: translating studies in breast cancer models to clinical insights.

Carol A. Lange(University of Minnesota), Britta M. Jacobsen(University of Colorado Health), Monique A. Spillman(University of Colorado Anschutz Medical Campus), Kathryn B. Horwitz(University of Colorado Boulder), Carol A. Sartorius(University of Colorado Anschutz Medical Campus), Hany Abdel-Hafiz(University of Arizona)
PubMed
January 1, 2008
Cited by 49

Related Papers

Identification of a RING protein that can interact in vivo with the BRCA1 gene product
|Nature Genetics|1996|752
Y chromosome loss in cancer drives growth by evasion of adaptive immunity
|Nature|2023|175
Inhibition of the CCL2 receptor, CCR2, enhances tumor response to immune checkpoint therapy
|Communications Biology|2020|170
The Transcription Factor ZEB1 Is Aberrantly Expressed in Aggressive Uterine Cancers
|Cancer Research|2006|165
The Inhibitory Function in Human Progesterone Receptor N Termini Binds SUMO-1 Protein to Regulate Autoinhibition and Transrepression
|Journal of Biological Chemistry|2002|146